To read more on this topic click here.
New molecule could reverse neurodegeneration in Parkinson’s
News
Author: Simge Eva DoganPublished: 11 October 2018
Prep:
Cook:
Serves:
Researchers at a university in Spain have discovered a new molecule which they claim can block and reverse neurodegeneration in Parkinson’s.
The molecule – named SynuClean-D – is able to reduce alpha-synuclein aggregations which cause degeneration.
The study – published in science journal ‘PNAS’ – explains how researchers at the Universitat Autònoma de Barcelona, Spain, tested over 14,000 molecules before discovering SynuClean-D.
They then tested the molecule on a Caenorhabditis worm – one of the most commonly used animals when researching neurodegenerative diseases – finding that it boosted its mobility and protected it from neural degeneration.
Salvador Ventura, the study coordinator, said: “Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative diseases such as Parkinson’s in the future.”
For more information on the latest Parkinson’s research please visit the EPDA website.
Last Month
Next Month
Share this story
Related articles
Global update
World Parkinson’s Congress 2016: travel grant applications now open
Financial support available for attendees travelling to WPC 2016
READ MORE
In my country
Parkinson’s in South Africa
An in-depth look at how Parkinson's is managed in South Africa
READ MORE
Perspectives
10 top tips for travelling with Parkinson’s
Finnish author and campaigner Timo Montonen shares his top tips
READ MORE
Comments